IRLAB Therapeutics Correlations

IRLAB-A Stock

SEK 1.58 -0.01 -0.63%

Current 90-days correlation between IRLAB Therapeutics and Bio Works Technologies AB is 0.04 (i.e., Very good diversification).The correlation coefficient ranges from -1 to +1 and quantifies how closely the stock co-moves with paired assets.

IRLAB Therapeutics Correlation to Market

Weak diversification

The correlation between IRLAB Therapeutics and Dow Jones is 0.48, which Macroaxis classifies as Weak diversification for the selected horizon. This chart helps evaluate whether adding Dow Jones genuinely reduces risk relative to holding IRLAB Therapeutics alone.

The correlation structure for IRLAB Therapeutics captures its relationship with related exposures. All figures are informational and reflect general regulatory context.

Moving together with IRLAB Stock

0.84	VITR	Vitrolife AB	Pair Corr
0.66	CAMX	Camurus AB	Pair Corr
0.76	GENO	Genovis AB	Pair Corr
0.8	BINV	BioInvent International	Pair Corr
0.68	XSPRAY	XSpray Pharma AB	Pair Corr
0.63	SEB-C	Skandinaviska Enskilda	Pair Corr
0.69	SEB-A	Skandinaviska Enskilda	Pair Corr

Moving against IRLAB Stock

0.58	INVE-B	Investor AB ser	Pair Corr
0.56	INVE-A	Investor AB ser	Pair Corr
0.45	VOLV-B	AB Volvo	Pair Corr
0.4	EGTX	Egetis Therapeutics	Pair Corr
0.39	SHB-A	Svenska Handelsbanken	Pair Corr

Related Correlations Analysis

	LIPUM	ISOFOL	BIOWKS	KDEV	INIT	ANNX	XBRANE	ALZ	ACTI	CLS-B
LIPUM		0.41	-0.25	0.49	-0.38	0.16	0.3	0.31	0.36	0.06	LIPUM
ISOFOL	0.41		-0.1	0.34	-0.02	0.18	-0.05	0.08	0.61	-0.13	ISOFOL
BIOWKS	-0.25	-0.1		-0.61	0.43	-0.33	-0.42	-0.45	-0.15	-0.35	BIOWKS
KDEV	0.49	0.34	-0.61		-0.22	0.59	0.34	0.45	0.33	0.14	KDEV
INIT	-0.38	-0.02	0.43	-0.22		0.3	-0.1	-0.08	-0.01	-0.05	INIT
ANNX	0.16	0.18	-0.33	0.59	0.3		0.45	0.39	0.19	0.31	ANNX
XBRANE	0.3	-0.05	-0.42	0.34	-0.1	0.45		0.72	-0.35	0.88	XBRANE
ALZ	0.31	0.08	-0.45	0.45	-0.08	0.39	0.72		-0.25	0.59	ALZ
ACTI	0.36	0.61	-0.15	0.33	-0.01	0.19	-0.35	-0.25		-0.5	ACTI
CLS-B	0.06	-0.13	-0.35	0.14	-0.05	0.31	0.88	0.59	-0.5		CLS-B
	LIPUM	ISOFOL	BIOWKS	KDEV	INIT	ANNX	XBRANE	ALZ	ACTI	CLS-B

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CLS-B	+ 0.88	XBRANE
ALZ	+ 0.72	XBRANE
ACTI	+ 0.61	ISOFOL
ANNX	+ 0.59	KDEV
CLS-B	+ 0.59	ALZ
KDEV	+ 0.49	LIPUM

High negative correlations

KDEV	- 0.61	BIOWKS
CLS-B	- 0.5	ACTI
ALZ	- 0.45	BIOWKS
XBRANE	- 0.42	BIOWKS
INIT	- 0.38	LIPUM
ACTI	- 0.35	XBRANE

Risk-Adjusted Indicators

There is a big difference between IRLAB Stock performing well and IRLAB Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IRLAB Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIPUM	0.89	-0.02	0.00	-0.77	0.00	0.00	2.57	-2.13	7.23
ISOFOL	2.91	-0.19	0.00	0.03	0.00	0.00	2.99	-4.17	50.92
BIOWKS	3.23	0.57	0.22	-1.39	2.69	-4.34	8.89	-4.50	17.17
KDEV	2.49	-0.70	0.00	3.81	0.00	0.00	3.57	-7.41	25.28
INIT	2.20	0.11	0.09	-0.39	2.60	-2.91	5.88	-5.12	19.49
ANNX	4.14	-0.28	0.00	-0.29	0.00	0.00	7.98	-8.33	44.62
XBRANE	3.31	-0.90	0.00	-6.88	0.00	0.00	5.12	-7.50	30.97
ALZ	3.28	-0.45	0.00	0.33	0.00	0.00	4.00	-5.63	57.67
ACTI	2.50	0.03	0.03	0.01	3.11	-3.01	4.42	-6.43	29.95
CLS-B	4.00	-0.32	0.00	0.80	0.00	0.00	7.51	-7.38	51.78

Be your own money manager

Portfolio optimization matters because investors need a repeatable way to decide whether adding IRLAB Therapeutics AB improves expected return without taking on disproportionate risk. A stronger allocation process asks what the position adds to the portfolio, not just what it might do on its own.

Did you try this?

Run Portfolio Volatility Now

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk

All Next

Launch Module

IRLAB Therapeutics Corporate Management

Governance context around IRLAB Therapeutics AB gives investors another way to assess whether decision-making power is balanced, accountable, and aligned with shareholder priorities. Institutions hold about 22.49% of shares while insiders own roughly 38.63%.

Nicholas Waters	Ex RD	Profile
Maria Jalmelid	Chief Operations	Profile
Joakim MD	Chief Officer	Profile
Richard MBA	Chief Officer	Profile
BSc BSc	Director HR	Profile
Clas Sonesson	Chief Officer	Profile
Viktor Siewertz	Chief Officer	Profile

Macroaxis provides analytical tools and reference data for investors of all levels to evaluate holdings and assess risk across market volatility, economic shifts, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC